Colorado Department of Public Health and Environment   Report issue

Government Phase 3
Founded: Glendale CO United States (1876)

Organization Overview

First Clinical Trial
2016
NCT02818777
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Colorado Department of Public Health and Environment

Active Ingredients

Drugs in Phase 3 Trials (2)

cannabidiol (Epidiolex) (3 trials)

tetrahydrocannabinol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 2)

Tremor (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2